• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Feds indict former Spectranetics execs

Feds indict former Spectranetics execs

September 1, 2010 By MassDevice staff

SPNC logo

A federal grand jury indicted Spectranetics Corp.’s (NSDQ:SPNC) former CEO, two other former executives and a consultant on charges stemming from their alleged illegal importation of laser medical devices for a clinical trial.

John Schulte, who resigned as CEO nearly two years ago, former vice president of business development Obinna “Larry” Adhigije, former business development manager Trung Pham and consultant Hernan Ricaurte were indicted Aug. 26 on 12 counts of conspiracy to defraud the federal government, lying to investigations, import violations and other charges. The indictments were unsealed Aug. 31.

Spectranetics paid $5 million and admitted responsibility to avoid federal prosecution late last year. The Colorado Springs-based company, which makes cardiac ablation lasers used to zap arterial plaque, agreed to pony up $4.9 million in civil damages and forfeit $100,000 to settle the case. Spectranetics also agreed to non-prosecution and corporate integrity agreements with the government.

Schulte, 62, of Wellesley, Mass., (who is currently president and CEO of Tewksbury, Mass.-based Mitralign Inc.) was arrested and appeared in federal court in Massachusetts yesterday. He, Adhigije, Pham and Ricaurte face up to 20 years in prison and fines of up to $250,000.

The indictments accuse the men of conspiring to “obstruct and defeat the law function of the FDA and U.S. Customs and Border Protection, specifically the inspecting, taxing, evaluating and clearing of medical devices imported in the United States” between January 2004 and October 2008, according to a press release.

According to the non-prosecution agreement the company signed last year, Spectranetics and some of its officials illegally imported medical laser equipment. The company ran clinical studies that didn’t comply with Food & Drug Administration regulations (the Coronary Graft Results after Atherectomy with Lasers or Coral trial and another trial of its models of its CVX-300 medical laser and CliRpath Turbo laser, Turbo Elite laser ablation and Turbo-Booster laser guide catheters), according to the Justice Dept. The company also promoted products with no FDA clearance, according to the DOJ. False Medicare claims were submitted from 2003 to 2008 as a result, the agency said.

Federal agents raided the company’s headquarters Sept. 4, 2008, according to the Colorado Springs Gazette.

Filed Under: Business/Financial News, Dental, Legal News, News Well Tagged With: Spectranetics Corp.

More recent news

  • Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump
  • Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor
  • Anaconda Biomed wins CE mark for funnel catheter
  • FDA approves Neuspera neuromod for urinary incontinence

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy